Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2022 06:00 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Plans to Continue Developing a Portfolio of Innovative Products such as Naltrexone Encompassing Transdermal Drug Delivery Applications for Addictions and Long-COVID

VANCOUVER, British Columbia, Nov. 07, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0) continues with its plans to develop a portfolio of innovative products encompassing transdermal drug...
October 21, 2022 06:00 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Pending Acquisition of Naltrexone Therapeutics Supported by Reports that Naltrexone Demonstrates Promising Long COVID Applications

VANCOUVER, British Columbia, Oct. 21, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0) which on October 11th signed a nonbinding Letter of Intent to acquire 100% of Naltrexone Therapeutics,...
October 18, 2022 06:00 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Update on Upcoming Launch of its Sponsored Psilocybin Trials at John Hopkins University

VANCOUVER, British Columbia, Oct. 18, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0) has provided an update on the launch of its psilocybin trials at John Hopkins University. LOVE...
October 12, 2022 06:21 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Signing of Non-Binding LOI to Acquire 100% of Naltrexone Therapeutics Inc., a Pharmaceutical Technology Company with Significant IP Related to the Transdermal Delivery of FDA Approved Naltrexone

VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0) has signed a non-binding Letter of Intent to acquire 100% of Naltrexone Therapeutics Inc., a...
September 22, 2022 06:00 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Launch of its Love Pharma Online Shop, a Fully Integrated e-Commerce Platform Featuring its Proprietary Products, BLOOM and Auralief

VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0), an international sexual health and wellness company, has launched its Love Pharma online shop, a...
September 08, 2022 06:00 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Strategic Investment in Starton Therapeutics, a New Jersey Based Clinical Stage Biotechnology Company

VANCOUVER, British Columbia, Sept. 08, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0), an international sexual health and wellness company, has made a strategic investment in Starton...
August 26, 2022 06:00 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Shareholders’ Letter from CEO Zach Stadnyk

VANCOUVER, British Columbia, Aug. 26, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0), an international sexual health and wellness company, has provided a shareholders’ update. Zach...
August 18, 2022 06:00 ET | Source: InvestmentPitch Media and Love Pharma Inc

InvestmentPitch Media Video Discusses LOVE Pharma’s Definitive Agreement to Acquire Doc Hygiene Pharmaceuticals Inc.

VANCOUVER, British Columbia, Aug. 18, 2022 (GLOBE NEWSWIRE) -- LOVE Pharma (CSE:LUV) (FSE:G1Q0), an international sexual health and wellness company, has entered into a definitive agreement to...